{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:14:08Z","timestamp":1793423648844,"version":"4.5.0"},"reference-count":100,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>Rosacea is a chronic inflammatory condition of which there is no cure. The pathogenesis of rosacea is likely multifactorial, involving genetic and environmental contributions. Current understanding suggests that pro-inflammatory pathways involving cathelicidins and inflammasome complexes are central to rosacea pathogenesis. Common rosacea triggers modulate these pathways in a complex manner, which may contribute to the varying severity and clinical presentations of rosacea. Established and emerging rosacea treatments may owe their efficacy to their ability to target different players in these pro-inflammatory pathways. Improving our molecular understanding of rosacea will guide the development of new therapies and the use of combination therapies.<\/jats:p>","DOI":"10.1177\/12034754241229365","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T07:52:15Z","timestamp":1709797935000},"page":"178-189","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":103,"title":["Rosacea: Pathogenesis and Therapeutic Correlates"],"prefix":"10.1177","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-095X","authenticated-orcid":false,"given":"Ryan S. Q.","family":"Geng","sequence":"first","affiliation":[{"name":"Temerty School of Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienn N.","family":"Bourkas","sequence":"additional","affiliation":[{"name":"School of Medicine, Queen\u2019s University, Kingston, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3514-9513","authenticated-orcid":false,"given":"Asfandyar","family":"Mufti","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6060-7272","authenticated-orcid":false,"given":"R. Gary","family":"Sibbald","sequence":"additional","affiliation":[{"name":"Temerty School of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"Dalla Lana School of Public Health and Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"bibr1-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1053\/sder.2001.27553"},{"key":"bibr2-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120625"},{"key":"bibr3-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18420"},{"key":"bibr4-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15122"},{"key":"bibr5-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.04.043"},{"key":"bibr6-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03472.x"},{"key":"bibr7-12034754241229365","doi-asserted-by":"publisher","DOI":"10.5070\/D32010024262"},{"key":"bibr8-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.08.049"},{"key":"bibr9-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1246-06.2006"},{"key":"bibr10-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.2010.02217.x"},{"key":"bibr11-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-012-1997-x"},{"key":"bibr12-12034754241229365","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00079"},{"key":"bibr13-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.351"},{"key":"bibr14-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13139"},{"key":"bibr15-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.222"},{"key":"bibr16-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1038\/jidsymp.2011.2"},{"key":"bibr17-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.08.028"},{"key":"bibr18-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00113.2014"},{"key":"bibr19-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1038\/nm1616"},{"key":"bibr20-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2009.04.007"},{"key":"bibr21-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939275"},{"key":"bibr22-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.58"},{"key":"bibr23-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13143"},{"key":"bibr24-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2014.09.002"},{"key":"bibr25-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.02.745"},{"key":"bibr26-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.141"},{"key":"bibr27-12034754241229365","volume-title":"Acne and Rosacea","author":"Plewig G","year":"2012"},{"key":"bibr28-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.2230"},{"key":"bibr29-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.53"},{"key":"bibr30-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00458-9"},{"key":"bibr31-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.03.030"},{"key":"bibr32-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16540"},{"key":"bibr33-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12030"},{"key":"bibr34-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08028.x"},{"key":"bibr35-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03704.x"},{"key":"bibr36-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02253.x"},{"key":"bibr37-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020542"},{"key":"bibr38-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01974.x"},{"key":"bibr39-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.47.1.61"},{"issue":"5","key":"bibr40-12034754241229365","first-page":"777","volume":"50","author":"Szlachcic A","year":"1999","journal-title":"J Physiol Pharmacol"},{"key":"bibr41-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(99)70493-7"},{"key":"bibr42-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1969.01610300033005"},{"key":"bibr43-12034754241229365","first-page":"29","volume":"17","author":"Dahl MV","year":"2001","journal-title":"Adv Dermatol"},{"key":"bibr44-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/928315"},{"key":"bibr45-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1004612"},{"key":"bibr46-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.08.027"},{"key":"bibr47-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.204"},{"key":"bibr48-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.07.021"},{"key":"bibr49-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3280127948"},{"key":"bibr50-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.019"},{"issue":"1","key":"bibr51-12034754241229365","first-page":"26","volume":"2","author":"Jones DA","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"key":"bibr52-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2010.01107.x"},{"key":"bibr53-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/s0162-3109(00)00192-2"},{"key":"bibr54-12034754241229365","doi-asserted-by":"publisher","DOI":"10.3980\/j.issn.2222-3959.2015.03.19"},{"key":"bibr55-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1080\/09629350020008682"},{"issue":"3","key":"bibr56-12034754241229365","first-page":"316","volume":"13","author":"Stein L","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"bibr57-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14437"},{"key":"bibr58-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-017-0176-3"},{"key":"bibr59-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-008-8007-8"},{"key":"bibr60-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/159354"},{"issue":"1","key":"bibr61-12034754241229365","first-page":"44","volume":"61","author":"Breneman DL","year":"1998","journal-title":"Cutis"},{"key":"bibr62-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1007\/BF01646108"},{"key":"bibr63-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.59.8.0010"},{"key":"bibr64-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1038\/srep37082"},{"key":"bibr65-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02130.x"},{"issue":"9","key":"bibr66-12034754241229365","first-page":"54","volume":"4","author":"Park H","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"bibr67-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1007\/s000110050216"},{"key":"bibr68-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.14"},{"key":"bibr69-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1177\/1099800409346333"},{"key":"bibr70-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00047.2010"},{"key":"bibr71-12034754241229365","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.2021.5925"},{"key":"bibr72-12034754241229365","unstructured":"Accuitis I. Safety and efficacy of ACU-D1 in the treatment of acne rosacea. 2018."},{"key":"bibr73-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93299-1"},{"key":"bibr74-12034754241229365","unstructured":"LLC AO, bioRasi LLC. A study to determine safety and efficacy of B244 in subjects with mild to moderate rosacea. clinicaltrials.gov (NCT03590366). 2019."},{"key":"bibr75-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10191"},{"key":"bibr76-12034754241229365","unstructured":"Inc CB, ethica Clinical Research I. CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes. clinicaltrials.gov (NCT04508205). 2019."},{"key":"bibr77-12034754241229365","unstructured":"Maruho Co L. Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle. clinicaltrials.gov (NCT02547441).2017."},{"key":"bibr78-12034754241229365","unstructured":"Dermata T. DMT310-005 Topical in the Treatment of Acne Rosacea. clinicaltrials.gov (NCT05108025). 2022."},{"key":"bibr79-12034754241229365","unstructured":"Amorepacific C. A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea. clinicaltrials.gov (NCT02583009).2016."},{"key":"bibr80-12034754241229365","unstructured":"Alfasigma SpA, bioRasi LLC. Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea. (NCT05150587). 2022."},{"key":"bibr81-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.11.038"},{"key":"bibr82-12034754241229365","unstructured":"Sol-Gel Technologies L. A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea. clinicaltrials.gov (NCT03448939).2019."},{"key":"bibr83-12034754241229365","unstructured":"Derm Research P. A Pilot Study on the Use of Seysara for Rosacea. clinicaltrials.gov (NCT04555525). 2020."},{"key":"bibr84-12034754241229365","unstructured":"Stanford U. Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea. clinicaltrials.gov (NCT03079531).2019."},{"key":"bibr85-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2021.1887138"},{"key":"bibr86-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.098"},{"key":"bibr87-12034754241229365","unstructured":"Johns Hopkins U. Timolol for the treatment of acne and rosacea. clinicaltrials.gov (NCT02774590). 2021."},{"key":"bibr88-12034754241229365","unstructured":"Tarsus Pharmaceuticals I. Study of TP-04 in participants with papulopustular rosacea. clinicaltrials.gov ( NCT05838170). 2023."},{"key":"bibr89-12034754241229365","unstructured":"Albany Research Institute I. Topical Mitogenic-Activated Protein Kinase (MAPK) Inhibition in Rosacea. clinicaltrials.gov (NCT05616923). 2022."},{"key":"bibr90-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18857"},{"key":"bibr91-12034754241229365","unstructured":"Hovione Scientia L. Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea. clinicaltrials.gov (NCT03263273). 2019."},{"key":"bibr92-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.01.043"},{"key":"bibr93-12034754241229365","unstructured":"Vyne Therapeutics I, Premier Research Group p. A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea. clinicaltrials.gov (NCT04608500). 2018."},{"key":"bibr94-12034754241229365","unstructured":"Vyne Therapeutics I, Premier Research Group p. A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea. clinicaltrials.gov (NCT03142451). 2018."},{"key":"bibr95-12034754241229365","unstructured":"Journey Medical C, Dr. Reddy\u2019s Laboratories L. A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. clinicaltrials.gov (NCT05296629). 2023."},{"key":"bibr96-12034754241229365","unstructured":"Journey Medical C, Dr. Reddy\u2019s Laboratories L. A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2). clinicaltrials.gov (NCT05343455).2023."},{"key":"bibr97-12034754241229365","unstructured":"Icahn School of Medicine at Mount S, Pfizer. PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea. (NCT06013371). 2024."},{"key":"bibr98-12034754241229365","unstructured":"Dermatology Consulting Services P. Evaluation of the Safety and Efficacy of Topical Roflumilast Cream in the Treatment of Facial Papulopustular Rosacea. clinicaltrials.gov (NCT05278624). 2023."},{"issue":"6","key":"bibr99-12034754241229365","first-page":"641","volume":"6","author":"Fowler JF","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"bibr100-12034754241229365","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.05.063"}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754241229365","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/12034754241229365","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754241229365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:50:31Z","timestamp":1777391431000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/12034754241229365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1177\/12034754241229365"],"URL":"https:\/\/doi.org\/10.1177\/12034754241229365","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}